{"id":2739,"date":"2020-10-09T13:55:38","date_gmt":"2020-10-09T13:55:38","guid":{"rendered":"https:\/\/www.lyomark.com\/?p=2739"},"modified":"2026-04-30T14:18:59","modified_gmt":"2026-04-30T14:18:59","slug":"neofact-feasibility-study-published","status":"publish","type":"post","link":"https:\/\/lyomark.com\/en\/neofact-machbarkeitsstudie-veroffentlicht\/","title":{"rendered":"Feasibility study on Neofact\u00ae published: The innovative LISA application aid Neofact\u00ae is successful."},"content":{"rendered":"<p class=\"wp-block-paragraph\">In a clinical trial conducted at T\u00fcbingen University Hospital, 20 preterm infants (gestational age \u2265 26 + 0\/7) were administered the surfactant Alveofact\u00ae (45 mg\/ml; Lyomark Pharma, Oberhaching, Germany) using the new LISA application aid, Neofact\u00ae. The aim of Neofact\u00ae was to enable a simple and gentle method for the administration of surfactant that works without the use of Magill forceps. Neofact\u00ae facilitates surfactant administration and is also suitable for any gestational age. This was confirmed by convincing results in the study. An extremely high success rate was achieved (95%), with complications occurring only rarely.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Neofact\u00ae was developed by Dr. Christian Maiwald in collaboration with Lyomark Pharma GmbH and MurrPlastik, and is already well-established in clinical practice.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Further information about the study can be found <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33023914\/\" target=\"_blank\" rel=\"noopener noreferrer\">here<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>In der am Universit\u00e4tsklinikum T\u00fcbingen durchgef\u00fchrten klinischen Studie wurde 20 Fr\u00fchgeborenen (Gestationsalter \u2265 26 + 0\/7) das Surfactant Alveofact\u00ae (45 mg \/ ml; Lyomark Pharma, Oberhaching, Deutschland) mit der neuen LISA-Applikationshilfe Neofact\u00ae verabreicht. Das Ziel von Neofact\u00ae war es, ein einfaches und schonendes Verfahren f\u00fcr die Applikation von Surfactant zu erm\u00f6glichen, das ohne die Verwendung [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":2437,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_seopress_analysis_target_kw":"","footnotes":""},"categories":[12],"tags":[22,18,27,28],"class_list":["post-2739","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-aktuelles","tag-alveofact","tag-lyomark-pharma","tag-surfactant","tag-wundheilung"],"_links":{"self":[{"href":"https:\/\/lyomark.com\/en\/wp-json\/wp\/v2\/posts\/2739","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lyomark.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lyomark.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lyomark.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/lyomark.com\/en\/wp-json\/wp\/v2\/comments?post=2739"}],"version-history":[{"count":2,"href":"https:\/\/lyomark.com\/en\/wp-json\/wp\/v2\/posts\/2739\/revisions"}],"predecessor-version":[{"id":4036,"href":"https:\/\/lyomark.com\/en\/wp-json\/wp\/v2\/posts\/2739\/revisions\/4036"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lyomark.com\/en\/wp-json\/wp\/v2\/media\/2437"}],"wp:attachment":[{"href":"https:\/\/lyomark.com\/en\/wp-json\/wp\/v2\/media?parent=2739"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lyomark.com\/en\/wp-json\/wp\/v2\/categories?post=2739"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lyomark.com\/en\/wp-json\/wp\/v2\/tags?post=2739"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}